These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 8698866)

  • 1. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K; Steil GM; Mittelman SD; Bergman RN
    J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.
    Rebrin K; Steil GM; Getty L; Bergman RN
    Diabetes; 1995 Sep; 44(9):1038-45. PubMed ID: 7657026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.
    Mittelman SD; Bergman RN
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E630-7. PubMed ID: 10950832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog.
    Sindelar DK; Chu CA; Rohlie M; Neal DW; Swift LL; Cherrington AD
    Diabetes; 1997 Feb; 46(2):187-96. PubMed ID: 9000693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production.
    Ader M; Bergman RN
    Am J Physiol; 1990 Jun; 258(6 Pt 1):E1020-32. PubMed ID: 2193527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation of the hepatic effects of growth hormone by its lipolytic activity.
    Piatti PM; Monti LD; Caumo A; Conti M; Magni F; Galli-Kienle M; Fochesato E; Pizzini A; Baldi L; Valsecchi G; Pontiroli AE
    J Clin Endocrinol Metab; 1999 May; 84(5):1658-63. PubMed ID: 10323396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
    Chu CA; Galassetti P; Igawa K; Sindelar DK; Neal DW; Burish M; Cherrington AD
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers.
    Pei D; Chen YD; Hollenbeck CB; Bhargava R; Reaven GM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3368-72. PubMed ID: 7593453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New concepts in extracellular signaling for insulin action: the single gateway hypothesis.
    Bergman RN
    Recent Prog Horm Res; 1997; 52():359-85; discussion 385-7. PubMed ID: 9238859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of endogenous glucose production by mild hyperinsulinemia during exercise is determined predominantly by portal venous insulin.
    Camacho RC; Pencek RR; Lacy DB; James FD; Wasserman DH
    Diabetes; 2004 Feb; 53(2):285-93. PubMed ID: 14747277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis.
    Fanelli CG; De Feo P; Porcellati F; Perriello G; Torlone E; Santeusanio F; Brunetti P; Bolli GB
    J Clin Invest; 1992 Jun; 89(6):2005-13. PubMed ID: 1602007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
    Kruszynska YT; Olefsky JM; Frias JP
    Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue.
    Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH
    Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog.
    Wolfe RR; Shaw JH
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E181-6. PubMed ID: 6141738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.